INVO Fertility Files 8-K: Material Agreements & Equity Updates
Ticker: IVF · Form: 8-K · Filed: Aug 22, 2025 · CIK: 1417926
Sentiment: neutral
Topics: material-agreement, equity-securities, corporate-action
TL;DR
INVO Fertility inked a big deal and sold some stock, filing an 8-K on 8/21/25.
AI Summary
On August 21, 2025, INVO Fertility, Inc. entered into a Material Definitive Agreement. The company also reported on Unregistered Sales of Equity Securities and Material Modifications to Rights of Security Holders. The filing includes Financial Statements and Exhibits.
Why It Matters
This 8-K filing indicates significant corporate actions by INVO Fertility, Inc., including new agreements and equity transactions, which could impact its financial standing and strategic direction.
Risk Assessment
Risk Level: medium — The filing details material definitive agreements and unregistered sales of equity, which can introduce financial and operational risks.
Key Players & Entities
- INVO Fertility, Inc. (company) — Registrant
- August 21, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- NAYA Biosciences, Inc. (company) — Former company name
- INVO Bioscience, Inc. (company) — Former company name
- EMY'S SALSA AJI DISTRIBUTION COMPANY, INC. (company) — Former company name
FAQ
What was the nature of the Material Definitive Agreement entered into by INVO Fertility, Inc. on August 21, 2025?
The filing indicates the entry into a Material Definitive Agreement on August 21, 2025, but the specific details of the agreement are not provided in the provided text.
What type of equity securities were sold in the unregistered sales reported by INVO Fertility, Inc.?
The filing mentions Unregistered Sales of Equity Securities, but the specific type and amount of securities are not detailed in the provided text.
What were the material modifications to the rights of security holders?
The filing notes Material Modifications to Rights of Security Holders, but the specifics of these modifications are not elaborated upon in the provided text.
When did INVO Fertility, Inc. change its name from NAYA Biosciences, Inc.?
INVO Fertility, Inc. changed its name from NAYA Biosciences, Inc. on October 22, 2024.
What is the business address and phone number for INVO Fertility, Inc.?
The business address for INVO Fertility, Inc. is 5582 BROADCAST COURT, SARASOTA, FL 34240, and the business phone number is (978) 878-9505.
Filing Stats: 1,362 words · 5 min read · ~5 pages · Grade level 12.8 · Accepted 2025-08-22 17:24:33
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value IVF The Nasdaq Stock Mark
- $1,751,343 — econd Amended and Restated Debenture to $1,751,343.75, (ii) remove provisions related to M
- $1,300,000 — econd Amended and Restated Debenture by $1,300,000 in exchange for receipt of shares of th
- $1,751,343.75 — 7%) per annum, and the principal sum is $1,751,343.75. The maturity date of the Amended and R
- $1.4765 — y common stock at a conversion price of $1.4765 per share, subject to adjustment as des
- $3,000,000 — ny receives gross proceeds of more than $3,000,000 from any equity or debt financings (oth
Filing Documents
- form8-k.htm (8-K) — 50KB
- ex4-1.htm (EX-4.1) — 200KB
- ex10-1.htm (EX-10.1) — 41KB
- ex10-2.htm (EX-10.2) — 25KB
- 0001641172-25-025270.txt ( ) — 533KB
- ivf-20250821.xsd (EX-101.SCH) — 3KB
- ivf-20250821_lab.xml (EX-101.LAB) — 33KB
- ivf-20250821_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 22, 2025 INVO FERTILITY, INC. /s/ Steven Shum Steven Shum Chief Executive Officer